Subscribe To
Oncocyte Reports First Quarter 2023 Financial Results
Nearing Manufacturing Start Up of First Kitted Product IRVINE, Calif., May 11, 2023 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today reported financial results for the first quarter 2023, ended March 31, 2023. First Quarter 2023 and Recent Highlights: Completed an equity capital raise of $13.86 million from the sale and issuance of common stock […] The post Oncocyte Reports First Quarter 2023 Financial Results appeared first on ForexTV...
Read More
Posted: May 11 2023, 12:00
Author Name: forextv
Views: 081773